Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm caused by a reciprocal translocation between chromosome 9 and 22, creating the oncogenic fusion gene BCR-ABL1, which encodes for a constitutively active tyrosine kinase [1]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.